BOT 1.37% 36.0¢ botanix pharmaceuticals ltd

Ann: Botanix Presents at Fall Clinical Dermatology Conference, page-54

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,544 Posts.
    lightbulb Created with Sketch. 318
    If our acne product delivers in phase 2, you may find as you do with many many american biotechs is that venture capitalists come along and organize funding for phase 3 as opposed to big pharma. Happens every week. So considering acne alone is a company maker what do you think that would mean for dermatitis? We talk bags and bags but in the American health sector, biotechs are valued much more highly than what we are. Consequently there is much room for improvement. Saying that, who would have thought we would be at 7.9c. If vesparum did, they are geniuses as someone just alluded to. My take on that was all about the timing and the continuity. We can all agree phase 2 acne started quite promptly. If those clowns who put their money in at 11c started buying the same amount now we would all be much happier.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
36.0¢
Change
-0.005(1.37%)
Mkt cap ! $707.4M
Open High Low Value Volume
36.5¢ 37.0¢ 36.0¢ $391.8K 1.080M

Buyers (Bids)

No. Vol. Price($)
3 160000 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 11013 2
View Market Depth
Last trade - 16.10pm 29/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.